Primary Site >> Liver Cancer

Gene >> SLC1A2

Journal: Oncogene. 2002 Nov 28;21(54):8293-301.
Title: New targets of beta-catenin signaling in the liver are involved in the glutamine metabolism.
Author: Cadoret, Axelle|Ovejero, Christine|Terris, Benoit|Souil, Evelyne|Levy, Laurence|Lamers, Wouter H|Kitajewski, Jan|Kahn, Axel|Perret, Christine
PMID: 12447692
Journal: Proc Natl Acad Sci U S A. 2004 Dec 7;101(49):17216-21.
Title: Liver-targeted disruption of Apc in mice activates beta-catenin signaling and leads to hepatocellular carcinomas.
Author: Colnot, S|Decaens, T|Niwa-Kawakita, M|Godard, C|Hamard, G|Kahn, A|Giovannini, M|Perret, C
PMID: 15563600
Journal: J Hepatol. 2005 Jun;42(6):842-9.
Title: Activation of the canonical Wnt/beta-catenin pathway confers growth advantages in c-Myc/E2F1 transgenic mouse model of liver cancer.
Author: Calvisi, Diego F|Conner, Elizabeth A|Ladu, Sara|Lemmer, Eric R|Factor, Valentina M|Thorgeirsson, Snorri S
PMID: 15885355
Journal: Oncogene. 2007 Feb 1;26(5):774-80.
Title: Differential effects of inactivated Axin1 and activated beta-catenin mutations in human hepatocellular carcinomas.
Author: Zucman-Rossi, J|Benhamouche, S|Godard, C|Boyault, S|Grimber, G|Balabaud, C|Cunha, A S|Bioulac-Sage, P|Perret, C
PMID: 16964294